MYX.L

MyCelx Technologies Corporation (DI)
MyCelx Tech. Corp. - Director Dealing
26th March 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 2395I
MyCelx Technologies Corporation
26 March 2024
 

26 March 2024

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified yesterday by Tom Lamb, Chairman of the Board of Directors of the Company, that on 25 March 2024, he purchased 2,000 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.50 per Common Share. Following this transaction, Mr. Lamb holds 313,175 Common Shares representing 1.36 per cent of the total issued capital of the Company.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Ana Ercegovic

 

 

Tel: + 44 20 7523 8000

Celicourt

Mark Antelme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

 

Notification of transactions of persons discharging managerial responsibility or connected persons

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Tom Lamb

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MYCELX Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

 

 

Common shares of US$0.025

 

 

ISIN: US62847T2024

 

 

b)

 

Nature of the transaction

 

 

Purchase of Common Shares in GBP

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.50

 

2,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

25/03/2024

f)

 

Place of the transaction

 

 

London Stock Exchange (AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFVLVRIEFIS]]>
TwitterFacebookLinkedIn